Bays Harold Edward, Shrestha Amardeep, Niranjan Varalakshmi, Khanna Monu, Kambhamettu Lalitha
Diplomate of American Board of Obesity Medicine, Medical Director/President Louisville Metabolic and Atherosclerosis Research Center, Clinical Associate Professor/University of Louisville Medical School, 3288 Illinois Avenue, Louisville, KY, 40213, USA.
Diplomate American Board of Obesity Medicine, Family Medical Clinic, Internal Medicine, Primary Care and Obesity Medicine, 1480 N Green Mount Road # 200, O'Fallon, IL, 62269, USA.
Obes Pillars. 2022 Jan 10;1:100006. doi: 10.1016/j.obpill.2021.100006. eCollection 2022 Mar.
Compared to other races/ethnicities, individuals from South Asia with obesity are strikingly susceptible to the presence of CVD risk factors and onset of CVD events - in part due to adiposopathic anatomic and metabolic responses to positive caloric balance. Pathogenic endocrine and immune effects of adipocyte hypertrophy and visceral fat accumulation both directly and indirectly promote among the most common metabolic diseases encountered in clinical practice - many being major cardiovascular disease (CVD) risk factors. This is especially applicable to those from South Asia - largely due to genetics, epigenetics, unhealthful nutrition, and physical inactivity.
This roundtable discussion included 4 obesity specialists engaged in the clinical management of obesity among patients of South Asian descent.
Patients with obesity from South Asia have increased adipocyte size, fewer (functional) adipocytes, and increased visceral adiposity accompanied by functional endocrine and immune abnormalities. This helps explain the increased CVD risk factors and increased CVD risk among this unique population. These CVD risk factors include increased prevalence of metabolic syndrome (even at lower body mass index relative to other races), insulin resistance, type 2 diabetes mellitus, increased lipoprotein (a), and adiposopathic dyslipidemia [(i.e., elevated triglyceride levels, reduced high density lipoprotein cholesterol levels, increased low density lipoprotein (LDL) particle number, and increased prevalence of smaller and denser LDL particles].
The four panelists of this roundtable discussion describe their practical diagnostic processes and treatment plans for patients from South Asia, with an emphasis on a patient-centered approach to obesity in this unique population.
与其他种族/族裔相比,肥胖的南亚人极易出现心血管疾病(CVD)风险因素并发生CVD事件——部分原因是对热量摄入正向平衡的脂肪病理解剖和代谢反应。脂肪细胞肥大和内脏脂肪堆积所产生的致病性内分泌和免疫效应,直接或间接地促成了临床实践中最常见的代谢性疾病——其中许多都是主要的心血管疾病(CVD)风险因素。这在很大程度上适用于南亚人——主要是由于遗传、表观遗传、不健康的营养和缺乏身体活动。
本次圆桌讨论包括4位从事南亚裔患者肥胖临床管理的肥胖专家。
来自南亚的肥胖患者脂肪细胞增大、(功能性)脂肪细胞数量减少、内脏脂肪增多,并伴有功能性内分泌和免疫异常。这有助于解释这一独特人群中CVD风险因素增加以及CVD风险升高的原因。这些CVD风险因素包括代谢综合征患病率增加(即使相对于其他种族,体重指数较低时)、胰岛素抵抗、2型糖尿病、脂蛋白(a)升高以及脂肪病理性血脂异常[即甘油三酯水平升高、高密度脂蛋白胆固醇水平降低、低密度脂蛋白(LDL)颗粒数量增加以及较小且致密的LDL颗粒患病率增加]。
本次圆桌讨论的四位小组成员描述了他们针对南亚患者的实际诊断过程和治疗计划,重点是以患者为中心的方法来处理这一独特人群的肥胖问题。